Caplin Point Laboratories Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Mar ' 25	Mar ' 24	Mar ' 23	Mar ' 22	Mar ' 21

Sources of funds

Owner's fund

Equity share capital

15.20

15.19

15.18

15.16

15.13

Share application money

-

14.22

15.37

8.96

14.80

Preference share capital

-

-

-

-

-

Reserves & surplus

1,685.73

1,360.74

1,109.36

906.53

728.75

Loan funds

Secured loans

-

-

-

-

0.01

Unsecured loans

-

-

-

-

-

Total

1,700.93

1,390.15

1,139.91

930.65

758.69

Uses of funds

Fixed assets

Gross block

373.51

313.13

279.61

263.73

264.08

Less : revaluation reserve

-

-

-

-

-

Less : accumulated depreciation

168.25

147.34

122.76

101.27

81.39

Net block

205.26

165.79

156.85

162.46

182.69

Capital work-in-progress

20.64

27.75

42.68

2.60

1.36

Investments

802.44

584.15

434.14

264.70

149.18

Net current assets

Current assets, loans & advances

786.14

744.62

669.51

624.40

527.78

Less : current liabilities & provisions

113.55

132.16

163.27

123.51

102.32

Total net current assets

672.59

612.46

506.24

500.89

425.46

Miscellaneous expenses not written

-

-

-

-

-

Total

1,700.93

1,390.15

1,139.91

930.65

758.69

Notes:

Book value of unquoted investments

490.19

345.08

-

-

0.70

Market value of quoted investments

-

1.09

21.00

-

11.20

Contingent liabilities

64.79

36.99

84.60

36.81

44.61

Number of equity sharesoutstanding (Lacs)

760.12

759.42

759.03

757.89

756.43